Adrenoleukodystrophy Drugs Market to Reach US$ 2.3 Billion by 2035...

added blog Networking

2026-08-05 11:38:20 -

Adrenoleukodystrophy Drugs Market to Reach US$ 2.3 Billion by 2035 Driven by Gene Therapy Advancements

The global Adrenoleukodystrophy (ALD) Drugs Market is poised for remarkable growth over the next decade, driven by rapid advancements in gene therapy, increasing awareness of rare genetic disorders, and expanding research initiatives. The market was valued at US$ 519.4 Mn in 2024 and is projected to grow at a CAGR of 13.9% from 2025 to 2035, surpassing **US$ 2.3 Bn by the end of 2035....

0 Comments 0 Shares 151 Views 0 Reviews